A quantitative structure-property relationship for predicting drug solubility in PEG 400/water cosolvent systems

被引:44
作者
Rytting, E
Lentz, KA
Chen, XQ
Qian, F
Venkatesh, S
机构
[1] Bristol Myers Squibb Co, Pharmaceut Res Inst, Pharmaceut Discovery, Preclin Candidate Optimizat, Wallingford, CT 06492 USA
[2] Bristol Myers Squibb Co, Pharmaceut Res Inst, Pharmaceut Discovery, Preclin Candidate Optimizat, Lawrenceville, NJ 08543 USA
关键词
cosolvent; in silico; PEG; 400; prediction; QSPR model; solubility;
D O I
10.1023/B:PHAM.0000016237.06815.7a
中图分类号
O6 [化学];
学科分类号
0703 ;
摘要
Purpose. A quantitative structure - property relationship (QSPR) was developed to predict drug solubility in binary mixtures of polyethylene glycol ( PEG) 400 and water. The ability of the QSPR model to predict solubility was assessed and compared to the classic log-linear cosolvency model. Methods. The solubility of 122 drugs, ranging in log P from - 2.4 to 7.5, was determined in 0%, 25%, 50%, and 75% PEG (v/v in water) by the shake-flask method. Solubility data from 84 drugs were fit by linear regression using the following molecular descriptors: molecular weight, volume, radius of gyration, density, number of rotatable bonds, hydrogen-bond donors, and hydrogen-bond acceptors. The multiple linear regression model was optimized by a genetic algorithm guided selection method. The remaining 38 compounds were used to test the predictability of the model. Results. QSPR-based models developed at each volume fraction with the training set compounds showed a reasonable correlation coefficient (r) of similar to0.9 and a root mean square (rms) error of < 0.5 log unit. The model predicted solubility values of similar to 78% of the testing set compounds within 1 log unit. The log-linear model was as effective as the QSPR-based model in predicting the testing set solubilities; however, many drugs, as expected, showed significant deviation from log-linearity. Conclusions. The QSPR model requires only the chemical structure of the drug and has utility for guiding vehicle identification for early preclinical in vivo studies, especially when compound availability is limited and experimental data such as aqueous solubility and melting point are unknown. When experimental data are available, the log-linear model was verified to be a useful predictive tool.
引用
收藏
页码:237 / 244
页数:8
相关论文
共 25 条
[1]  
BURLEY SK, 1988, ADV PROTEIN CHEM, V39, P125
[2]   Prediction of aqueous solubility of organic compounds using a quantitative structure-property relationship [J].
Chen, XQ ;
Cho, SJ ;
Li, Y ;
Venkatesh, S .
JOURNAL OF PHARMACEUTICAL SCIENCES, 2002, 91 (08) :1838-1852
[3]   Genetic algorithm guided selection: Variable selection and subset selection [J].
Cho, SJ ;
Hermsmeier, MA .
JOURNAL OF CHEMICAL INFORMATION AND COMPUTER SCIENCES, 2002, 42 (04) :927-936
[4]  
GRANT DJW, 1990, SOLUBILITY BEHAV ORG, P12
[5]   SOLUBILITY OF HYDROCORTISONE IN ORGANIC AND AQUEOUS-MEDIA - EVIDENCE FOR REGULAR SOLUTION BEHAVIOR IN APOLAR SOLVENTS [J].
HAGEN, TA ;
FLYNN, GL .
JOURNAL OF PHARMACEUTICAL SCIENCES, 1983, 72 (04) :409-414
[6]   Comparison of various cosolvency models for calculating solute solubility in water-cosolvent mixtures [J].
Jouyban-Gharamaleki, A ;
Valaee, L ;
Barzegar-Jalali, M ;
Clark, BJ ;
Acree, WE .
INTERNATIONAL JOURNAL OF PHARMACEUTICS, 1999, 177 (01) :93-101
[7]   Aqueous solubility of diclofenac diethylamine in the presence of pharmaceutical additives: A comparative study with diclofenac sodium [J].
Khalil, E ;
Najjar, S ;
Sallam, A .
DRUG DEVELOPMENT AND INDUSTRIAL PHARMACY, 2000, 26 (04) :375-381
[8]   Predicting cosolvency.: 1.: Solubility ratio and solute log Kow [J].
Li, A ;
Yalkowsky, SH .
INDUSTRIAL & ENGINEERING CHEMISTRY RESEARCH, 1998, 37 (11) :4470-4475
[9]   EXTENDED HILDEBRAND SOLUBILITY APPROACH - METHYLXANTHINES IN MIXED-SOLVENTS [J].
MARTIN, A ;
PARUTA, AN ;
ADJEI, A .
JOURNAL OF PHARMACEUTICAL SCIENCES, 1981, 70 (10) :1115-1120
[10]   Solubilization by cosolvents -: Establishing useful constants for the log-linear model [J].
Millard, JW ;
Alvarez-Núñez, FA ;
Yalkowsky, SH .
INTERNATIONAL JOURNAL OF PHARMACEUTICS, 2002, 245 (1-2) :153-166